← Back to Clinical Trials
Recruiting NCT07250568

NCT07250568 Office Program Effects on Pain, Posture, Muscle Physiology, Stress, Ergonomics, and Quality of Life in LBP Workers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07250568
Status Recruiting
Phase
Sponsor Suci Wahyu Ismiyasa
Condition Low Back Pain
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2026-03-23
Primary Completion 2026-06-17

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 58 Years
Study Type INTERVENTIONAL
Interventions
ExerciseEducationAdvice

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2026-03-23 with a primary completion date of 2026-06-17.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This interventional study aims to evaluate the effectiveness of an office worker's program in reducing low back pain and improving physical and psychosocial outcomes among office employees. The primary objective is to determine the effects of the intervention on pain, lumbar posture, muscle physiology (including core stability, flexibility, fatigue, and endurance), ergonomics, stress levels, and quality of life across different intervention groups. Participants will be assigned to one of three groups: Group 1: Exercise program, posture education, and standing advice Group 2: Posture education and standing advice Group 3: standing advice only The study will compare outcomes between groups to identify which combination of interventions provides the greatest benefits for office workers with a tendency to experience low back pain.

Eligibility Criteria

Inclusion Criteria: 1. Identified LBP 2. Age between 18 - 60 years old 3. In the office, working in front computer/laptop minimum along 4 hours per day 4. Able to ambulate independently with or without walking aids 5. Controlled comorbidity e.g. DM, HPT, managed asthma and controlled thyroid conditions Exclusion Criteria: 1. Recumbent 2. Cancer, spinal fracture, neurological disorder (stroke, PBI and soon) 3. Participation in a current fitness program designed to prevent LBP recurrence 4. Spinal operation within the last six months 5. Pregnant 6. Medication (steroid therapy, non-steroidal anti-inflammatory drugs (NSAIDs), opioids, muscle relaxants, antidepressants or anxiolytics) 7. Insufficient to finish outcome measurements and exercise program 8. Participants who do not attend 3 consecutive weeks or 8 consecutive times

Contact & Investigator

Central Contact

Suci Wahyu Ismiyasa

✉ suciwahyuismiyasa@gmail.com

📞 +6285219163441

Principal Investigator

Suci Wahyu Ismiyasa, M.Erg

PRINCIPAL INVESTIGATOR

Universiti Teknologi Mara

Frequently Asked Questions

Who can join the NCT07250568 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 58 Years, studying Low Back Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07250568 currently recruiting?

Yes, NCT07250568 is actively recruiting participants. Contact the research team at suciwahyuismiyasa@gmail.com for enrollment information.

Where is the NCT07250568 trial being conducted?

This trial is being conducted at Depok, Indonesia.

Who is sponsoring the NCT07250568 clinical trial?

NCT07250568 is sponsored by Suci Wahyu Ismiyasa. The principal investigator is Suci Wahyu Ismiyasa, M.Erg at Universiti Teknologi Mara. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology